Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.
Anaesth Crit Care Pain Med. 2023 Aug;42(4):101225. doi: 10.1016/j.accpm.2023.101225. Epub 2023 Apr 6.
The present study aims to compare the hemodynamic profile of lidocaine and fentanyl during propofol induction of general anesthesia.
This randomized controlled trial included patients aged above 60 years undergoing elective non-cardiac surgery. The included patients received either 1 mg/kg lidocaine (n = 50) or 1 mcg/kg fentanyl (n = 50) based on total body weight with propofol induction of anesthesia. Patient's hemodynamics were recorded every minute for the first 5 min then every 2 min until 15 min after induction of anesthesia. Hypotension (mean arterial pressure [MAP] <65 mmHg or >30% reduction from baseline) was treated by intravenous 4 mcg bolus of norepinephrine. Outcomes included norepinephrine requirements (primary), the incidence of postinduction hypotension, MAP, heart rate, intubation condition, and postoperative delirium via the cognitive assessment method.
Forty-seven patients in the lidocaine group and 46 patients in the fentanyl group were analyzed. None in the lidocaine group experienced hypotension, while 28/46 (61%) of patients in the fentanyl group developed at least one episode of hypotension requiring a median (25th and 75th quartiles) norepinephrine dose of 4 (0,5) mcg, p-value <0.001 for both outcomes. The average MAP was lower in the fentanyl group than in the lidocaine group at all time points after anesthesia induction. The average heart rate was comparable between the two groups nearly at all time points after anesthesia induction. The overall intubation condition was comparable between the two groups. None of the included patients developed postoperative delirium.
Lidocaine-based regimen for induction of anesthesia reduced the risk of postinduction hypotension in older patients compared to the fentanyl-based regimen.
本研究旨在比较利多卡因和芬太尼在丙泊酚全身麻醉诱导时的血液动力学特征。
这是一项随机对照试验,纳入了年龄在 60 岁以上、择期行非心脏手术的患者。根据总体重,患者接受 1mg/kg 利多卡因(n=50)或 1mcg/kg 芬太尼(n=50),并接受丙泊酚麻醉诱导。患者的血液动力学在麻醉诱导后的前 5 分钟内每分钟记录一次,然后每 2 分钟记录一次,直到麻醉诱导后 15 分钟。低血压(平均动脉压[MAP]<65mmHg 或与基线相比下降>30%)用静脉注射 4 mcg 去甲肾上腺素治疗。主要结局为去甲肾上腺素的需求(主要结局)、诱导后低血压的发生率、MAP、心率、插管条件和术后谵妄通过认知评估方法。
利多卡因组 47 例患者和芬太尼组 46 例患者被纳入分析。利多卡因组无患者发生低血压,而芬太尼组 28/46(61%)例患者至少发生一次低血压,需要去甲肾上腺素中位数(25 分位数和 75 分位数)剂量为 4(0,5)mcg,p 值均<0.001。麻醉诱导后所有时间点,芬太尼组的平均 MAP 均低于利多卡因组。麻醉诱导后几乎所有时间点,两组的平均心率均相似。两组的总体插管条件相似。所有纳入患者均未发生术后谵妄。
与芬太尼相比,利多卡因用于麻醉诱导可降低老年患者诱导后低血压的风险。